Ocean Biomedical Inc. (OCEA)
Ocean Biomedical Statistics
Share Statistics
Ocean Biomedical has 166.01M shares outstanding. The number of shares has increased by 305.74% in one year.
| Shares Outstanding | 166.01M |
| Shares Change (YoY) | 305.74% |
| Shares Change (QoQ) | 303.76% |
| Owned by Institutions (%) | 13.38% |
| Shares Floating | 142.05M |
| Failed to Deliver (FTD) Shares | 541.39K |
| FTD / Avg. Volume | 0.96% |
Short Selling Information
The latest short interest is 2.93M, so 2.08% of the outstanding shares have been sold short.
| Short Interest | 2.93M |
| Short % of Shares Out | 2.08% |
| Short % of Float | 2.5% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -4.61 and the forward PE ratio is -0.03. Ocean Biomedical's PEG ratio is 0.
| PE Ratio | -4.61 |
| Forward PE | -0.03 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | -0.16 |
| P/FCF Ratio | -3.64 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Ocean Biomedical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02, with a Debt / Equity ratio of -0.17.
| Current Ratio | 0.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | -0.17 |
| Debt / EBITDA | - |
| Debt / FCF | -3.9 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-471.57K |
| Employee Count | 7 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -97.87% in the last 52 weeks. The beta is 1.63, so Ocean Biomedical's price volatility has been higher than the market average.
| Beta | 1.63 |
| 52-Week Price Change | -97.87% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.66 |
| Relative Strength Index (RSI) | 32.18 |
| Average Volume (20 Days) | 56.12M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | 0 |
| Net Income | -3.3M |
| EBITDA | 0 |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.34 |
Balance Sheet
The company has 0 in cash and 16.3M in debt, giving a net cash position of -16.3M.
| Cash & Cash Equivalents | 0 |
| Total Debt | 16.3M |
| Net Cash | -16.3M |
| Retained Earnings | -205.53M |
| Total Assets | 902K |
| Working Capital | -33.08M |
Cash Flow
In the last 12 months, operating cash flow was -4.18M and capital expenditures 0, giving a free cash flow of -4.18M.
| Operating Cash Flow | -4.18M |
| Capital Expenditures | 0 |
| Free Cash Flow | -4.18M |
| FCF Per Share | -0.15 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OCEA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for OCEA.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -383.56 |
| Piotroski F-Score | 0 |